13-transmembrane protein expressed in prostate cancer
US7306796B2 · kind B2 · utility
6Cited by
13References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2002 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Aug 4, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.